BR0211749A - Processo para a preparação de derivados de 4-(imidazol-1-il)benzenossulfonamida - Google Patents

Processo para a preparação de derivados de 4-(imidazol-1-il)benzenossulfonamida

Info

Publication number
BR0211749A
BR0211749A BR0211749-5A BR0211749A BR0211749A BR 0211749 A BR0211749 A BR 0211749A BR 0211749 A BR0211749 A BR 0211749A BR 0211749 A BR0211749 A BR 0211749A
Authority
BR
Brazil
Prior art keywords
imidazol
formula
preparation
benzenesulfonamide derivatives
derivatives
Prior art date
Application number
BR0211749-5A
Other languages
English (en)
Other versions
BR0211749B1 (pt
BRPI0211749B8 (pt
Inventor
Carmen Almansa Rosales
Concepcion Gonzalez Gonzalez
Original Assignee
Uriach & Cia Sa J
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uriach & Cia Sa J filed Critical Uriach & Cia Sa J
Publication of BR0211749A publication Critical patent/BR0211749A/pt
Publication of BR0211749B1 publication Critical patent/BR0211749B1/pt
Publication of BRPI0211749B8 publication Critical patent/BRPI0211749B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
    • C07C311/39—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/40—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68—Halogen atoms

Abstract

"PROCESSO PARA A PREPARAçãO DE DERIVADOS DE 4-(IMIDAZOL-1-IL)BENZENOSSULFONAMIDA". A presente invenção refere-se a um processo para a preparação de derivados de 4-(imidazol-1-il)benzenossulfonamida da fórmula I, onde R^ 1^ representa opcionalmente heteroarila ou arila substituída, que compreende tratar um composto da fórmula II, onde R^ 1^ tem o mesmo significado definido na fórmula I e Bu^ t^ representa terc-butila, com um ácido. Os derivados de 4(imidazol-1-il)benzenossulfonamida da fórmula I são úteis como agentes antiinflamatórios.
BRPI0211749A 2001-08-07 2002-08-01 processo para a preparação de derivados de 4-(imidazol-1- il)benzenossulfonamida BRPI0211749B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200101853A ES2184633B1 (es) 2001-08-07 2001-08-07 Procedimiento para la preparacion de derivados de 4-(imidazol-1-il) bencenosulfonamida.
PCT/ES2002/000385 WO2003016285A1 (es) 2001-08-07 2002-08-01 Procedimiento para la preparacion de derivados de 4-(imidazol-1-il)bencenosulfonamida

Publications (3)

Publication Number Publication Date
BR0211749A true BR0211749A (pt) 2004-10-13
BR0211749B1 BR0211749B1 (pt) 2013-09-10
BRPI0211749B8 BRPI0211749B8 (pt) 2021-05-25

Family

ID=8498662

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0211749A BRPI0211749B8 (pt) 2001-08-07 2002-08-01 processo para a preparação de derivados de 4-(imidazol-1- il)benzenossulfonamida

Country Status (17)

Country Link
US (2) US7351836B2 (pt)
EP (1) EP1424329B1 (pt)
JP (1) JP4309262B2 (pt)
KR (1) KR100888905B1 (pt)
AR (2) AR037231A1 (pt)
AT (1) ATE396976T1 (pt)
BR (1) BRPI0211749B8 (pt)
CA (1) CA2456531C (pt)
CY (1) CY1108861T1 (pt)
DE (1) DE60226879D1 (pt)
DK (1) DK1424329T3 (pt)
ES (2) ES2184633B1 (pt)
HK (1) HK1066214A1 (pt)
MX (1) MXPA04001147A (pt)
NO (1) NO326162B1 (pt)
PT (1) PT1424329E (pt)
WO (1) WO2003016285A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2015DN00202A (pt) 2012-07-12 2015-06-12 Chiesi Farma Spa
WO2022269384A1 (en) * 2021-06-24 2022-12-29 Ami Organics Ltd. A process for the direct synthesis of fedratinib intermediate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TNSN99111A1 (fr) * 1998-06-11 2005-11-10 Pfizer Derives de sulfonylbenzene nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
DE69935913T2 (de) * 1998-07-02 2008-01-10 Cryptography Research Inc., San Francisco Leckresistente aktualisierung eines indexierten kryptographischen schlüssels
AR024222A1 (es) * 1998-10-16 2002-09-25 Palau Pharma Sa Imidazoles con actividad antiinflamatoria un procedimiento para su preparacion y composiciones farmaceuticas que lo contienen
ES2159489B1 (es) 2000-03-23 2002-04-16 Uriach & Cia Sa J Nuevos derivados de imidazol con actividad antiinflamatoria.

Also Published As

Publication number Publication date
AR086065A2 (es) 2013-11-13
KR20040020079A (ko) 2004-03-06
ES2184633A1 (es) 2003-04-01
US8476456B2 (en) 2013-07-02
MXPA04001147A (es) 2004-07-08
AR037231A1 (es) 2004-11-03
ES2307817T3 (es) 2008-12-01
JP2005502659A (ja) 2005-01-27
CY1108861T1 (el) 2014-08-13
NO326162B1 (no) 2008-10-13
KR100888905B1 (ko) 2009-03-16
CA2456531A1 (en) 2003-02-27
BR0211749B1 (pt) 2013-09-10
DE60226879D1 (de) 2008-07-10
WO2003016285A8 (es) 2003-08-28
ATE396976T1 (de) 2008-06-15
EP1424329A1 (en) 2004-06-02
WO2003016285A1 (es) 2003-02-27
EP1424329B1 (en) 2008-05-28
US7351836B2 (en) 2008-04-01
US20090012307A1 (en) 2009-01-08
HK1066214A1 (en) 2005-03-18
NO20040981L (no) 2004-03-05
ES2184633B1 (es) 2004-08-01
BRPI0211749B8 (pt) 2021-05-25
DK1424329T3 (da) 2008-09-29
CA2456531C (en) 2010-12-14
JP4309262B2 (ja) 2009-08-05
PT1424329E (pt) 2008-08-06
US20040242872A1 (en) 2004-12-02

Similar Documents

Publication Publication Date Title
BR9917518A (pt) Processos para a preparação de pestecidas 1-arilpirazóis e seus intermediários
BR0210464A (pt) Composto, composição farmacêutica, processo para preparar um composto, e, uso de um composto
BRPI0410037A (pt) inibidores da fosfatidilinositol 3-cinase
DK0956282T3 (da) Sulfinsyrederivater, fremgangsmåde til deres fremstilling og anvendelse
BR0314379A (pt) Quinazolinonas espirocondensadas e a sua utilização como inibidores de fosfodiesterase
BRPI0510409A (pt) heterociclos bicìclicos contendo nitrogênio como inibidores da aromatase
BR0211427A (pt) Compostos, processo para preparar os mesmos, composição adequada para combater fungos danosos, uso de compostos, e, processo para combater fungos danosos
BR9812895A (pt) Processo para a preparação de derivados de triazolintiona
BRPI0416690A (pt) derivados de pirrol
BR0211291A (pt) Derivados de diamina, processo para produção dos derivados de diamina e fungicidas contendo os derivados de diamina como ingrediente ativo
ATE239001T1 (de) Verfahren zur herstellung von triazolinthion- derivaten
BRPI0411209A (pt) uso de derivados isoindolinona como inseticidas
BR0016678A (pt) Composto, formulação farmacêutica, uso de um composto, método para profilaxia ou tratamento de uma arritmia, e, processo para preparação de um composto
BRPI0108990B8 (pt) processo para preparação de derivados de pirimidona com atividade antifungos
BR0113259A (pt) Processo para a preparação de um composto, composto e processo para a preparação de compostos
BR0112745A (pt) Processo para a preparação de arilacetilaminotiazóis
ATE405671T1 (de) Zusammensetzungen zur verbesserung der card(catalyzed reporter deposition)-technik
BR0211903A (pt) Isoxazolopiridinonas
BR9813217A (pt) Tetraciclos, processo para a produção dos mesmos e preparações farmacêuticas contendo estes compostos
BR0208131A (pt) Derivados biguanida
BR9911250A (pt) Processo para preparação de compostos
BR0211749A (pt) Processo para a preparação de derivados de 4-(imidazol-1-il)benzenossulfonamida
BR9912870A (pt) Processo para sìntese de derivados de (1h) - benzo (c)quinolizina-3-onas
BR0208967A (pt) Monoazocorantes fibrorreativos
BRPI0607560A2 (pt) derivados de tienopiridina e o uso dos mesmos como moduladores de hsp90

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: PALAU PHARMA, S.A. (ES)

Free format text: TRANSFERIDO DE: J. URIACH AND CIA. S.A.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DA INT.CL: C07D 233/68, C07D 233/64, C07C 311/16

Ipc: C07D 233/68 (2011.01), C07D 233/64 (2011.01), C07C

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 10/09/2013, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 01/08/2002 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 01/08/2022